MindMed Soars 8.5%: Phase 3 Trial a Go

Shares of MindMed (MNMD) gained 8.5% percent on Monday to close the day at $7.37 per share. MindMed is a biopharmaceutical company, pioneers...

Three Stocks: Mind Medicine, CrowdStrike, and Hewlett Packard

Mind Medicine Shares of Mind Medicine (MNMD) traded as much as 20% lower today in the wake of an announcement from an FDA advisory committee. The...

Three Stocks: American Airlines, Mind Medicine, and GameStop

American Airlines American Airlines (AAL) shares closed the day 13% lower after the company adjusted their upcoming quarterly earnings expectations...

Three Stocks: MindMed, Gold, and Costco

MindMed Despite the market’s headwinds, MindMed (MNMD)’s shares are trading 6% higher today as the stock has two drivers in place. Robert Barrow,...

Three Stocks: MindMed, Ulta, and Intel

Mind Medicine MindMed (MNMD) was on the move again today, looking for another 50% gain according to my chart. If you don’t know about this stock,...

MindMed's Set to Pass a Psychological Market Test

It’s a little ironic (strangely I hear Alanis Morissette singing that as I type) that I’m talking about psychological levels with a psychedelic...

Three Stocks: MindMed, Tesla, and Dollar Tree

Mind Medicine What a ride it has been for Mind Medicine (MNMD) investors. We saw the stock shoot through the sky last week on news that the FDA had...

This is Just the Beginning of Mind Medicine

It’s déjà vu all over again, right? No, this is different. My colleague Nick Riso penned an incredibly timely article on Monday. The piece,...

Three Stocks: SoundHound AI, Mind Medicine, and Microchip Technology

SoundHound AI SoundHound (SOUN) is at it again as the stock is following a classic pattern of finding support at round numbers. Last week, I wrote...

MindMed Stock Forecast: Look for 545% Growth

The legal psychedelics market could be worth $6.86 billion by 2027, says Data Bridge Market Research.

That's a 241% climb from $2.01...

Pages 1 of 1